3van den Brand JA,van Dijk PR,Hofstra JM,et al.Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy[J].J Am Soc Nephrol,2014,25(1):150-158.
4Eriguchi M,Oka H,Mizobuchi T,et al.Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone[J].Nephrol Dial Transplant,2009,24(10):3082-3088.
5Hladunewich MA,Troyanov S,Calafati J,et al.The natural history of the non-nephrotic membranous nephropathy patient[J].Clin J Am Soc Nephrol,2009,4(9):1417-1422.
6Burstein DM,Korbet SM,Schwartz MM.Membranous glomerulonephritis and malignancy[J].Am J Kidney Dis,1993,22(1):5-10.
7Laluck BJ,Jr.,Cattran DC.Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy[J].Am J Kidney Dis,1999,33(6):1026-1032.
8Shiiki H,Saito T,Nishitani Y,et al.Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan[J].Kidney Int,2004,65(4):1400-1407.
9du Buf-Vereijken PW,Branten AJ,Wetzels JF.Idiopathic membranous nephropathy:outline and rationale of a treatment strategy[J].Am J Kidney Dis,2005,46(6):1012-1029.
10Kidney Disease Improving Global Outcomes(KDIGO) Glumerulonephritis Work Group.Chapter 7:Idiopathic membranous nephropathy[J].Kidney Int Suppl(2011),2012,2(2):186-197.
